retatrutide triple agonist weight loss trial Lilly orforglipron oral GLP-1 phase 3 Retatrutide, a TRIPLE agonist (GLP1,
Description
Can a doctor or biologist explain why GLP-1 use leads to increased heart-rate
GLP-1s have made injecting at home feel normal
For individuals with visceral adiposity related to specific medical conditions, specialist referral is the appropriate pathway rather than self-directed use of unlicensed agents
BSA agents can enhance the clearance of THs and may reduce the blood levels and effects of levothyroxine by interfering with the absorption of the drug
